Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct;41(10):1403-1409.
doi: 10.1097/PAS.0000000000000885.

Pathologic Separation of Chronic Hypersensitivity Pneumonitis From Fibrotic Connective Tissue Disease-associated Interstitial Lung Disease

Affiliations

Pathologic Separation of Chronic Hypersensitivity Pneumonitis From Fibrotic Connective Tissue Disease-associated Interstitial Lung Disease

Andrew Churg et al. Am J Surg Pathol. 2017 Oct.

Abstract

Chronic (fibrotic) hypersensitivity pneumonitis (HP) and fibrosing interstitial pneumonias associated with connective tissue disease (CTD-ILD) can be difficult to distinguish in biopsy specimens. To investigate features that might separate these entities, 2 pathologists blinded to the diagnoses reviewed 16 cases of chronic HP and 12 cases of CTD-ILD. Fifteen predefined parameters were examined by morphometric point counting, analysis/cm of lung tissue, or presence/absence. Germinal centers were present in a minority of patients, but favored a diagnosis of CTD-ILD (7/12 CTD vs. 2/16 HP; odds ratio, 9.80 [95% confidence interval, 1.50-63.4]; P=0.02). The number of lymphoid aggregates/cm (4.4±3.1 vs. 1.4±1.0; P=0.001), volume proportion of plasma cells (0.076±0.058 vs. 0.031±0.023; P=0.031), and plasma cell: lymphocyte ratio (1.03±0.71 vs. 0.35±0.22; P=0.001) were all significantly higher in CTD compared with HP. A diagnosis of HP was more common in the presence of peribronchiolar metaplasia (12/16 HP vs. 4/12 CTD; odds ratio, 6.00 [95% confidence interval, 1.15-31.2]; P=0.033) and in patients with a greater fraction of bronchioles showing peribronchiolar metaplasia (0.41±0.33 vs. 0.16±0.27; P<0.001). Number of fibroblast foci/cm, distribution of fibroblast foci, pattern of fibrosis, presence of giant cells/granulomas, and volume proportion of lymphocytes or eosinophils did not distinguish chronic HP from CTD-ILD. We conclude that no single morphologic measure definitively separates chronic HP from CTD-ILD lung biopsies, but numerous foci of peribronchiolar metaplasia favor HP, while the presence of germinal centers, large numbers of lymphoid aggregates, or a high plasma cell: lymphocyte ratio suggests CTD-ILD. Multidisciplinary discussion is often necessary for accurate classification inthis setting.

PubMed Disclaimer